Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)
This study has been completed.
Study NCT00135473   Information provided by German Competence Network Sepsis

First Received on August 24, 2005.   Last Updated on July 28, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Severe Sepsis
Septic Shock
Additional conditions recognized in this trial
Sepsis
Shock
Shock, Septic
Toxemia
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
Actrapid® (Insulin)
Additional drug interventions recognized in this trial
Hetastarch
Insulin
More general drug interventions related to this trial
Blood Substitutes
Hematologic Agents
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Plasma Substitutes
Therapeutic Uses
Sponsors listed in this trial
German Competence Network Sepsis
German Federal Ministry of Education and Research
B. Braun Melsungen AG
Novo Nordisk
HemoCue Gmbh, Großostheim, Germany


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services